Artificial neural network systems to predict the response to sintilimab in squamous-cell non-small-cell lung cancer based on data of ORIENT-3 study
The four ANN systems showed high accuracy, robustness and stability in predicting the response to sintilimab for patients with sqNSCLC.
Authors
- Puyuan Xing
- Le Tang (ORCID: https://orcid.org/0000-0002-5192-3329)
- Tongji Xie (ORCID: https://orcid.org/0000-0002-3276-9645)
- Guangyu Fan (ORCID: https://orcid.org/0000-0003-1561-0007)
- Yuankai Shi
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Publication Details
- Journal
- Cancer Immunology Immunotherapy
- Published
- 2024-12-21
- DOI
- https://doi.org/10.1007/s00262-024-03886-0
- Citations
- 2
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.57
Funders
- Innovent Biologics